Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
Description: TherapeuticsMD, Inc. operates as a women?s health care product company. The company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics. It offers prenatal vitamins, iron supplements, vitamin D supplements, natural menopause relief products, and cosmetic stretch mark creams under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||19.27%||Sales Growth - Q/Q||5.1%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-66.27%||ROE||-75.16%||ROI|
|Current Ratio||8.7||Quick Ratio||8.61||Long Term Debt/Equity||Debt Ratio||0.13|
|Gross Margin||76.69%||Operating Margin||-395.98%||Net Profit Margin||-395.47%||Dividend Payout Ratio|
|Cash From Financing Activities||59.48 M||Cash From Investing Activities||-40 K||Cash From Operating Activities||-19.15 M||Gross Profit||3.43 M|
|Net Profit||-20.89 M||Operating Profit||-20.92 M||Total Assets||99.48 M||Total Current Assets||96.71 M|
|Total Current Liabilities||11.11 M||Total Debt||Total Liabilities||11.77 M||Total Revenue||4.48 M|
|High 52 week||7.42||Low 52 week||3.56||Last close||4.23||Last change||0.71%|
|RSI||16.67||Average true range||0.18||Beta||0.08||Volume||1.72 M|
|Simple moving average 20 days||-10.95%||Simple moving average 50 days||-19.55%||Simple moving average 200 days||-21.3%|
|Performance Week||-8.64%||Performance Month||-23.37%||Performance Quart||-19.27%||Performance Half||-29.15%|
|Performance Year||-27.32%||Performance Year-to-date||11.02%||Volatility daily||1.58%||Volatility weekly||3.54%|
|Volatility monthly||7.26%||Volatility yearly||25.16%||Relative Volume||90.61%||Average Volume||2.78 M|
|New High||New Low|
2019-06-12 07:25:35 | Jim Cramer Shares His Thoughts On TherapeuticsMD, Rite Aid And More
2019-06-11 08:02:33 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-06-10 09:39:01 | TherapeuticsMD Enters Agreement to Market Drugs Outside US
2019-06-10 08:03:34 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-06-10 07:00:00 | TherapeuticsMD to Host Investor and Analyst Day Today
2019-06-06 08:06:53 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-06-04 08:02:42 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-05-29 07:00:00 | TherapeuticsMD to Host Investor and Analyst Day on June 10, 2019 in New York City
2019-05-07 14:06:00 | Here's Why TherapeuticsMD Fell as Much as 17.6% Today
2019-05-07 08:07:02 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-05-07 01:16:37 | Edited Transcript of TXMD earnings conference call or presentation 6-May-19 8:30pm GMT
2019-05-06 22:14:07 | TherapeuticsMD Inc TXMD Q1 2019 Earnings Call Transcript
2019-05-06 18:45:10 | TherapeuticsMD TXMD Reports Q1 Loss, Misses Revenue Estimates
2019-05-06 17:33:37 | TherapeuticsMD: 1Q Earnings Snapshot
2019-05-06 16:05:00 | TherapeuticsMD Announces First Quarter 2019 Financial Results
2019-05-06 08:50:12 | Implied Volatility Surging for TherapeuticsMD TXMD Stock Options
2019-05-03 10:38:40 | Is TherapeuticsMD Inc TXMD A Good Stock To Buy?
2019-04-30 08:04:54 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-04-29 07:00:00 | TherapeuticsMD to Report First Quarter 2019 Results on May 6, 2019
2019-04-17 07:00:00 | TherapeuticsMD Announces Commercial Availability of BIJUVA™ in the U.S.
2019-04-12 12:08:44 | Is TherapeuticsMD, Inc. NASDAQ:TXMD Overpaying Its CEO?
2019-04-06 08:03:00 | Here's Why Investors Are Betting Against These 2 Biotech Stocks
2019-03-28 08:05:00 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-03-12 10:27:05 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-03-05 08:03:31 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-02-28 07:00:00 | TherapeuticsMD Announces Participation in Two Upcoming Investor Conferences
2019-02-25 09:03:02 | TherapeuticsMD TXMD Catches Eye: Stock Jumps 6.1%
2019-02-22 09:11:53 | TherapeuticsMD, Inc. TXMD Q4 2018 Earnings Conference Call Transcript
2019-02-22 01:46:10 | Edited Transcript of TXMD earnings conference call or presentation 21-Feb-19 9:30pm GMT
2019-02-21 17:59:19 | TherapeuticsMD: 4Q Earnings Snapshot
2019-02-21 16:05:00 | TherapeuticsMD Announces Fourth Quarter and Full-Year 2018 Financial Results
2019-02-21 13:55:44 | Is TherapeuticsMD, Inc.’s NASDAQ:TXMD Balance Sheet Strong Enough To Weather A Storm?
2019-02-08 08:04:46 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-02-08 07:00:00 | TherapeuticsMD to Report Fourth Quarter and Full Year 2018 Results on February 21, 2019
2019-02-04 21:46:00 | Here's What Pushed TherapeuticsMD 37.8% Higher in January
2019-01-17 08:51:01 | Implied Volatility Surging for TherapeuticsMD TXMD Stock Options
2019-01-17 08:06:19 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-01-15 08:03:20 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.